Bencycloquidium bromide

Bencycloquidium bromide, a muscarinic M (3) receptor antagonist, is an anticholinergic compound that acts as an anticholinergic bronchodilator. Bencycloquidium bromide can be used in the study for rhinitis[1][2].

Product Specifications

CAS Number

860804-18-8

UNSPSC

12352005

Target

MAChR

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Inflammation/Immunology; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/bencycloquidium-bromide.html

Solubility

10 mM in DMSO

Smiles

C[N+]1(CC2)CCC2C(C1)OCC(C3CCCC3)(C4=CC=CC=C4)O.[Br-]

Molecular Formula

C21H32BrNO2

Molecular Weight

410.39

References & Citations

[1]Qin Xu, et al. Determination of bencycloquidium bromide in rat plasma by liquid chromatography-electrospray ionization-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 1;846 (1-2) :209-14.|[2]Jun-Xia Jiang, et al. Characterization of bencycloquidium bromide, a novel muscarinic M (3) receptor antagonist in guinea pig airways. Eur J Pharmacol. 2011 Mar 25;655 (1-3) :74-82.